|
|
| November 11, 2008: Dr. Paul Gurbel presents the results of a study of a new anti-platelet drug (PRT060128) |
Dr. Paul Gurbel presents the results of a study of oral dosing of PRT060128, a novel
direct-acting, reversible P2Y12 antagonist overcomes high platelet reactivity in patients
non-responsive to clopidogrel therapy at the 2008 AHA Scientific Sessions
[ Download video ] |
|
No comments have been submitted
|